What sector does GlaxoSmithKline Pharmaceuticals Limited (GLAXO) operate in?
GlaxoSmithKline Pharmaceuticals Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) current stock price?
As of the latest data, GlaxoSmithKline Pharmaceuticals Limited stock price is ₹2,710.40, with a previous close of ₹2,743.30. GlaxoSmithKline Pharmaceuticals Limited lost -₹32.90 in the last trading session, representing a -1.2% loss.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) current market capitalization?
GlaxoSmithKline Pharmaceuticals Limited market cap is approximately 459.16 billion.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Earnings Per Share (EPS)?
The trailing EPS is ₹50.66, and the forward EPS is ₹59.40.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Price-to-Earnings (P/E) ratio?
GlaxoSmithKline Pharmaceuticals Limited current P/E ratio is 53.5, with a forward P/E of 45.63.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) EBITDA?
GlaxoSmithKline Pharmaceuticals Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.27 billion.
Does GlaxoSmithKline Pharmaceuticals Limited (GLAXO) dividends?
Yes. GlaxoSmithKline Pharmaceuticals Limited pays semiannual dividends with a forward yield of 0.89% and a forward payout of ₹24.00 per share.
When is the next ex-dividend date for GlaxoSmithKline Pharmaceuticals Limited (GLAXO)?
The next ex-dividend date is scheduled for May 07, 2025.
When is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) next earnings report?
GlaxoSmithKline Pharmaceuticals Limited is expected to release its next earnings report on June 30, 2025.
What is GlaxoSmithKline Pharmaceuticals Limited (GLAXO) beta (volatility) score?
GlaxoSmithKline Pharmaceuticals Limited has a beta of 0.129, indicating lower volatility than the overall market.
